Navegar por autor "Noriega Concepción, Victor"

Mostrando ítems 1-11 de 11

Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

2025-05- Serrano, Josefina; Martínez-Cuadrón, David; Gil, Cristina; Bernal, Teresa; Tormo, Mar; [et al.]
Autologous stem cell transplantation in patients with mantle cell lymphoma: A retrospective study of the geltamo group (1994-2011)

2014- Noriega Concepción, Victor
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

2022- Labrador, J.; Martínez-Cuadrón, D.; De La Fuente, A.; Rodríguez-Veiga, R.; Serrano, J.; [et al.]
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

2022- Martínez-Cuadrón, D.; Serrano, J.; Mariz, J.; Gil, C.; Tormo, M.; [et al.]
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

2023- Bernal, T.; Moreno, A.F.; de LaIglesia, A.; Benavente, C.; García-Noblejas, A.; [et al.]
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

2023- Bernal, T.; Moreno, A.F.; de LaIglesia, A.; Benavente, C.; García-Noblejas, A.; [et al.]
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

2021-06- Martínez-Cuadrón, David; Serrano, Josefina; Gil, Cristina; Tormo, Mar; Martínez-Sánchez, Pilar; [et al.]
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry

2025-11- Alfonso Pierola, Ana; Martínez-Cuadrón, David; Rodríguez-Veiga, Rebeca; Gil, Cristina; Martínez-Sánchez, Pilar; [et al.]
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

2024- Martínez-Cuadrón, D.; Megías-Vericat, J.E.; Gil, C.; Bernal, T.; Tormo, M.; [et al.]
THE AGE >65 YEARS AND RESPONSE TO THE RECOVERY TREATMENT, PRINCIPAL FACTORS THAT AFFECT THE SURVIVAL OF PATIENTS WITH NON HODGKIN LYMPHOMA IN RELAPSE/ REFRACTORIES, TREATED WITH R-ESHAP AND AUTO-TPH

2015- López Fernández, María Fernanda; Debén Ariznavarreta, Guillermo; Fernandez Lopez, Carlos; Torres Carrete, Juan Pío; Noriega Concepción, Victor; [et al.]
The Complete Mutatome and Clonal Architecture of Del(5q)

2015- Noriega Concepción, Victor